Skip to Main Content

Paper Details

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma.
Blood Adv
8
2023
Author NameAffiliation
Lohith GowdaYale School of Medicine, Yale University
  • 1 - 1

Datasets

Release 1.2